The influence of lung microbiota on lung carcinogenesis, immunity and immunotherapy
Resumen: Microbiota have emerged as key modulators of both the carcinogenic process and the immune response against cancer cells, and, thus, it seems to influence the efficacy of immunotherapy. While most studies have focused on analyzing the influence of gut microbiota, its composition substantially differs from that in the lung. Here, we describe how microbial life in the lungs is associated with host immune status in the lungs and, thus, how the identification of the microbial populations in the lower respiratory tract rather than in the gut might be key to understanding the lung carcinogenic process and to predict the efficacy of different treatments. Understanding the influence of lung microbiota on host immunity may identify new therapeutic targets and help to design new immunotherapy approaches to treat lung cancer.
Idioma: Inglés
DOI: 10.1016/j.trecan.2019.12.007
Año: 2020
Publicado en: Trends in Cancer In press (2020), 1-12
ISSN: 2405-8033

Factor impacto SCIMAGO:

Tipo y forma: Review (Published version)
Área (Departamento): Área Microbiología (Dpto. Microb.Med.Pr.,Sal.Públ.)
Área (Departamento): Área Inmunología (Dpto. Microb.Med.Pr.,Sal.Públ.)

Creative Commons You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you may not distribute the modified material.

Exportado de SIDERAL (2020-02-04-10:23:25)

Este artículo se encuentra en las siguientes colecciones:

 Record created 2020-02-04, last modified 2020-02-04

Versión publicada:
Rate this document:

Rate this document:
(Not yet reviewed)